Submitted by Anonymous (not verified) on 19 December 2025 - 15:12
Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 15, Status: Authorised
Source: